Vazquez-Urrutia, J.R. et al. 2026. Incidence and Prognostic Value of TP53, STK11, and KEAP1 Mutations Between De Novo Versus Recurrent Actionable Mutation–Negative Non-Small Cell Lung Cancer: A Single-Center Retrospective Study. World Journal of Oncology. 17, 3 (Jan. 2026), 310–321. DOI:https://doi.org/10.14740/wjon2761.